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Abstract
Objective We aimed to improve Tc-99m DTPA glomerular
filtration rate (GFR) scintigraphy (Gates’method) in a prospec-
tive study using Cr-51 EDTA GFR test as a gold standard.
Methods Fifty-seven Tc-99m DTPA GFR scintigrams in 45
subjects (male/female=33:12, age=45.9±17.6 years, 14
healthy volunteers and 31 nephrectomised patients) were com-
pared using Cr-51 EDTA GFR tests. Using the %renal uptake
of Tc-99mDTPA and Cr-51 EDTAGFR, a revised equation for
GFR was established through linear regression analysis.
Results The revised equation for improved GFR was GFR(mL/
min)=(%renal uptake×11.7773)−0.7354. Gates’ original GFRs
(70.1±20.5 mL/min/1.73 m2) were significantly lower than Cr-
51 EDTA GFRs (97.0±31.9 mL/min/1.73 m2; P<0.0001), but
the improved GFRs (98.0±26.3 mL/min/1.73 m2) were not
different from (P=0.7360) and had a significant correlation with
(r=0.73, P<0.0001) the Cr-51 EDTA GFRs. The revised GFR
equation effectively demonstrated perioperative GFR changes in
kidneys that were operated on and the contralateral kidneys at 3
and 6 months post-partial nephrectomy (n=25).
Conclusions GFRmeasurement using Tc-99m DTPA scintig-
raphy could be significantly improved by a revised equation
derived from the comparison with Cr-51 EDTA GFR.
Key Points
•Measurement of glomerular filtration rate is difficult follow-
ing nephrectomy.
• Measurements can be significantly improved by new renal
sctintigraphic methods .
• This helps physicians to measure kidney function of patients
following nephrectomy.
• Management of renal tumour patients should become more
effective .
Keywords Gamma camera imaging . Glomerular filtration
rate . Tc-99mDTPA . Nephrectomy . Cr-51 EDTA
Introduction
Chronic kidney disease is amajor life-threatening diseaseworld-
wide [1, 2]. Glomerular filtration rate (GFR) assessment is
extremely important in the management of chronic kidney
disease; abnormal GFR is closely related to cardiovascular
morbidity and premature mortality [3, 4]. The inulin clearance
test is considered the gold standard test for GFR [1], but
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technical difficulties inherent in the test have resulted in re-
searchers simplifying the original protocol of the test [5, 6] or
seeking other filtration agents, whether radioactive or non-
radioactive [1, 7]. Estimated GFR (eGFR) from the Modifica-
tion of Diet in Renal Disease (MDRD) Study reflecting serum
creatinine (sCr) level, age, gender and ethnicity seems to be the
most frequently advocated substitute method for measured GFR
[3, 8]. Currently, an eGFRof less than 60mL/min/1.73m2 of the
body surface area (BSA) is considered to indicate kidney disease
that requires attention from both patients and physicians to
prevent renal morbidity and mortality [2, 4]. However, some
calibration issues in themeasurement of sCr andmethodological
issues in the calculation of eGFR have not yet been properly
addressed [8–10]. Furthermore, ethnic differences can affect the
eGFR, requiring the adjustment of coefficients for different
ethnic populations [6, 11]. Thus, the current consensus regarding
the utility of eGFR is that it plays a limited role in evaluating
kidney function, in particular for patients with a GFR greater
than 60 mL/min/1.73 m2 [12, 13].
Recent advancements in surgical techniques have enabled
nephron-sparing surgery, even in patients with malignant renal
tumours. Robot-assisted or laparoscopic partial nephrectomy has
emerged as a promising surgical technique, especially in patients
with small renal tumours [14, 15]. Accordingly, the need for
accurate and facile evaluation of preoperative and postoperative
kidney function has drastically increased [16, 17]. However,
accurate evaluation of perioperative GFR changes is challenging
because the expected GFR is usually above the range in which
eGFR gives reliable estimates. Furthermore, direct measurement
of GFR was not possible in most imaging studies using indirect
GFR surrogates [18–20]. To our knowledge, theGFRof remnant
renal tissue in individual kidneys after partial nephrectomy has
never been directly assessed by any other method.
Gates’ method involves gamma camera imaging-based
measurement of GFR using Tc-99m DTPA (diethylene-
triaminepentaacetic acid) [21, 22]. Tc-99m DTPA is almost
completely excreted through glomerular filtration without re-
absorption or secretion at tubular levels. There is a specific time
period when the renal uptake of Tc-99m DTPA is closely
correlated with true GFR (i.e. a 2- to 3-min period post-
intravenous injection of Tc-99m DTPA) [21]. Individual and
total GFRs are readily obtained using Gates’ method because
the percentage renal uptake of Tc-99m DTPA, the main param-
eter of Gates’method, can be easily calculated using a region of
interest (ROI) analysis over simple dynamic gamma camera
imaging. Since its introduction in 1982, Gates’ method has
been available as commercial software built in to most current
gamma cameras [22, 23]. However, GFR measurement using
Gates’ method has been seriously criticised, mainly because of
its unreliability and inaccuracy, especially for high GFR levels
[24–27]. Therefore, even when accurate and facile measure-
ment of both individual and total GFRs had become a major
interest, particularly for urologists who are performing
nephron-sparing surgeries, the lack of refinement in Gates’
original method has limited its utility for urologists and nuclear
medicine physicians.
Thus, in the current study, we aimed to improve Gates’
method using the Cr-51 EDTA (ethylenediaminetetraacetic
acid) GFR test as a gold standard. In brief, we first investigat-
ed the reproducibility of Tc-99m DTPA GFR scintigraphy,
which is conducted in our institute, to address the reliability in
comparison with sCr-based eGFR. Second, we revised Gates’
original GFR equation from the %renal uptake of Tc-99m
DTPA using the Cr-51 EDTA GFR test as the gold standard.
Last, perioperative GFR changes after partial nephrectomy
were evaluated using the revised equation in another cohort
of patients with renal tumours.
Materials and methods
Patients
This study was conducted with the permission of the institu-
tional ethics review board. All subjects provided written in-
formed consent. Fourteen healthy volunteers (male/female=
9:5; age, 26.07±6.43 years) with normal blood test and uri-
nalysis results (Table 1), who represented the normal-to-high
GFR cohort, were prospectively recruited first. Of these 14
volunteers, 12 (male/female=7:5; age, 25.0±6.65 years)
underwent Tc-99mDTPAGFR scintigram twicewithin 7 days
to evaluate the reproducibility of GFR measurements. In
addition, 31 patients who had undergone unilateral nephrec-
tomy (male/female=24:7; age, 54.9±13.0 years) for renal cell
cancer (n =25), transitional cell cancer (n =3), kidney dona-
tion (n =2) and renal angiomyolipoma (n =1) were prospec-
tively enrolled to represent a cohort with moderately impaired
GFRs. Of these 31 patients, 20 underwent partial and 11 had
undergone total nephrectomy 2.7±5.0 months before the
study. There were 16 hypertensive and 3 diabetic patients in
the nephrectomy cohort. However, they had only mild-to-
moderate hypertension requiring minimal medication, such
as a single-agent calcium channel blocker, and none of the
patients received diuretics or angiotensin-converting enzyme
inhibitors that are known to affect GFR. No diabetic patients
were under insulin treatment and no clinically confirmed
vasculopathies, such as diabetic retinopathy or coronary artery
disease, were reported in the diabetic patients. The volunteers
(n =14) and nephrectomised patients (n =31) were not statis-
tically different from each other in terms of gender proportion,
blood biochemical markers (total protein, albumin, aspartate
aminotransferase and alanine aminotransferase), and urinaly-
sis results (albuminuria and glycosuria; P >0.05). However,
the nephrectomised patients were significantly older (P <
0.0001) and had more impaired renal function (P=0.0062
for sCr, and P <0.0001 for eGFR) than the healthy volunteers
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(Table 1). These two patient cohorts, described above, were
used for the generation of the revised GFR equation.
In addition, we retrospectively recruited a different patient
cohort (n =25; male/female=19:6; age=53.2±11.6 years)
who had undergone unilateral partial nephrectomy resulting
from renal cell carcinoma (n =23), angiomyolipoma (n =1)
and a renal cyst (n =1). Tc-99m DTPA GFR scintigrams were
performed as a baseline 1 month (35.0±5.2 days; range, 30–
49 days) before surgery. Follow-up Tc-99m DTPA GFR
scintigrams were done twice at 3 months (95.4±10.6 days;
range, 73–114 days) and 6 months (185.6±10.2 days; range
164–207 days) after surgery. In the retrospective study, we
intended to test the utility of the revised GFR equation.
Tc-99m DTPA GFR scintigraphy
Thirty minutes before the scintigram, patients were instructed
to ingest 500 mL of water. Then, patients lay in a supine
position on the table of a single-headed gamma camera (Ar-
gus, ADAC/Philips). The camera detector was located below
the table 30 cm from the patient. A cold vial of commercial
DTPA (TechneScan® DTPA, Mallinckrodt) was reconstituted
with Tc-99m pertechnetate (chemical impurity <10 μg Al/mL
Tc-99m, radiochemical purity >95 %) that was eluted out of
the Mo-99/Tc-99m generator (Technetium-99m Generator,
Samyoung Unitech), yielding Tc-99m DTPA. A butterfly
needle was first inserted into an antecubital vein in an upper
extremity, and then Tc-99m DTPA (185 MBq) was injected.
Without delay, 10 mL of normal saline was rapidly flushed
into the vein. Dynamic serial images were acquired for 20 min
thereafter: twenty 3-s images for flow and eighty 15-s images
for function. The 20 % energy window was set at an energy
peak of 140 keV. The image matrix was 128×128. Before the
injection, pre-injection counts were obtained for 60 s; imme-
diately after patient image acquisition, post-injection counts
were obtained for another 60 s. Injected radioactivity was
defined as the difference between pre- and post-injection
counts, measured in counts per second.
GFR calculation from the Tc-99m DTPA GFR scintigraphy
GFRmeasurement was performed using quantitative software
(PMOD, version 3.13, PMODTechnologies). The contours of
individual kidneys and the corresponding backgrounds were
drawn as shown in Fig. 1a. The area under the curve (AUC),
representing the radioactivity of individual kidneys, was ob-
tained 2–3 min post-injection of Tc-99m DTPA (Fig. 1b),
which had been the optimal time point for GFR estimation
in our previous study [28]. The renal radioactivity was
attenuation-corrected using the previously determined formu-
la for renal depth [23]. The resultant equation used for %renal
DTPA uptake in the current study was as follows:
%renalDTPAuptake ¼ RK−RBð Þ=e−μRD þ LK−LBð Þ=e−μLD 
 100=injectedcounts
where RK is the number of counts from the right kidney, RB is
the number of counts in the right kidney background, RD is
the renal depth of the right kidney (in centimetres), LK is the
number of counts from the left kidney, LB is the number of
counts from the left kidney background, LD is the renal depth
of the left kidney (in centimetres), and μ is the attenuation
coefficient of Tc-99m in soft tissue (0.153/cm).
Cr-51 EDTA GFR test
The gold standard in the current study was the Cr-51 EDTA
GFR test with two plasma samples [29, 30]. Cr-51 EDTA stock
solution (37 MBq/10 mL, GE Healthcare) was diluted 1:10
with normal saline.Whole blood (5mL) was aspirated from the
Table 1 Characteristics of the
study participants





Volunteers (n=14) Nephrectomised patients (n =31) P value
Age (years) 26.07±6.43 54.9±13.0 <0.0001
Male/female 9:5 24:7 NS
Blood biochemical markers
Total protein (g/dL) 7.2±0.45 7.4±0.56 NS
Albumin (g/dL) 4.6±0.26 4.4±0.34 NS
AST (IU/L) 20.0±8.1 22.4±12.1 NS
ALT (IU/L) 18.6±13.1 20.7±9.2 NS
Urinalysis
Albuminuria None n =1 NS
Glycosuria None n =2 NS
Renal function
Serum creatinine (mg/dL) 0.88±0.18 1.13±0.27 0.0062
eGFR (mL/min/1.73 m2) 96.6±12.9 67.7±17.0 <0.0001
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patients 3 h and 5 h post-injection of Cr-51 EDTA [dose=1.85–
2.96 MBq (50–80 μCi)]. After centrifugation (3,000 rpm for
8 min), 2 mL of plasma was obtained from each blood sample,
the plasma was separated into two aliquots for duplication
(1 mL per aliquot) and stored at room temperature until gamma
counting. Two or 3 days later, radioactivity in each aliquot was
counted for 20 min using an automatic gamma counter (1480
WIZARD 3”, Perkin-Elmer). Decay and background correc-
tions were performed. The average of the duplicated plasma
aliquots was used for data analysis. The clearance of Cr-51
EDTAwas calculated using the following equations.































where t1=3 h, t2=5 h, δt =2 h, C1 = first plasma sample
counts and C2 = second plasma sample counts. BSA indicates
body surface area calculated using the DuBois equation:
BSA(m2)=0.007184×weight(kg)0.425×height(cm)0.725.
One day after the first session of gamma counting as de-
scribed above, the whole-plasma samples were gamma counted
once more. The average GFR from the two sessions of gamma
counting was used for the final data analysis.
Serum creatinine-based estimation of GFR
The abbreviated MDRD equation was used for GFR estima-
tion from the serum creatinine (sCr) level [3, 8]. The sCr level
was measured using a chemistry analyser (Toshiba 200FR,
Toshiba Medical Systems) with Roche kinetic compensated
Jaffe reagent. The assay is calibrated with a lyophilised human
serum calibrator (C.f.a.s., Roche Diagnostics) in which the
sCr level is traceable to an isotope-dilution mass spectrometry
determination. The equation used for GFR estimation was






¼ 175 sCr−1:154  age−0:203  0:742 if femaleð Þ
Statistical analysis
Data are represented as the mean ± standard deviation if not
otherwise indicated. Reproducibility was analysed using coef-
ficients of variation (CV) and intra-class correlations (ICC)
between the first and second estimates. Paired t tests, Pearson’s
correlation test and Bland–Altman analysis were used for com-
parisons between the two estimates. Non-parametric analyses,
such as the Wilcoxon signed-rank sum test, or Mann–Whitney
U test were used for comparisons when a normal distribution
could not be assumed. Serial change of GFRs was tested using
generalised estimating equation. STATA (version 12.0.0) was










Fig. 1 Method used to delineate regions of interest (ROIs) for %renal
uptake. a ROIs were drawn along the renal contour for renal radioactivity.
Curvilinear ROIs were drawn at the lower lateral portion of the individual
kidneys for background activity correction. b At 2–3 min post-injection
of Tc-99mDTPA, the radioactivity counts for the area under curve (AUC)
were obtained for %renal uptake of Tc-99m DTPA. Please note that the
right kidney shows a smaller contour than the left kidney resulting from a
previous partial nephrectomy
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Results
Reproducibility of Tc-99m DTPA GFR scintigraphy
First, we investigated the reproducibility of %renal uptake and
gamma camera-based GFRmeasurements in comparison with
measurements obtained from the sCr level and the eGFR.
Here, we used Gates’ original GFR equation in order to
represent the gamma camera-based GFR.
The 12 volunteers (male/female=7:5; age, 25.0±6.65 years)
underwent Tc-99m DTPA GFR scintigram twice within a 1-
week interval. The sCr levels and eGFR were also checked
twice on the same day as the Tc-99m DTPA GFR scintigram.
The %renal uptakes were 10.24 %±1.60 % and 9.95 %±
1.62 % for the first and second measurements, respectively; a
significant difference was not found between the two measure-
ments (P=0.1763, Wilcoxon signed-rank sum test). The sCr
levels were 0.88±0.18 mg/dL and 0.88±0.28 mg/dL for the
first and second measurements, respectively, and were not
significantly different, either (P=0.9658). However, the mea-
surement of %renal uptake was more reproducible than that of
sCr level as demonstrated in Fig. 2a and b, which was quanti-
tatively supported by the lower %CV (5.41 %) and the greater
ICC (0.94) for the %renal uptake compared with the %CV
(9.50 %) and the ICC (0.93) for the sCr level (Table 2).
The gamma camera-based GFRs derived from the %renal
uptakes were 86.4±17.3 mL/min/1.73 m2 and 83.4±15.8 mL/
min/1.73 m2 for the first and second measurements, respec-
tively, and were not significantly different (P=0.1763). The
eGFRs calculated from the sCr levels were 97.05±13.7 mL/
min/1.73m2 and 100.5±20.6mL/min/1.73 m2 for the first and
second measurements, respectively; the eGFRs of the two
measurements were not significantly different either (P=
0.7646). However, data plotting (Fig. 2c, d) clearly showed
that the gamma camera-based GFR was more reproducibly
measured than the eGFR, which was also reflected by the
lower %CV (6.60%) and the higher ICC (0.94) for the gamma
camera-based GFR compared with the %CV (10.8 %) and the
ICC (0.76) for the eGFR (Table 2).
A revised equation for improved GFR measurement
The Cr-51 EDTA GFR (97.0±31.9 mL/min/1.73 m2; range,
13.6–153.2 mL/min/1.73 m2) was compared with Gates’ orig-
inal GFR in 45 subjects (14 healthy volunteers and 31 unilat-
erally nephrectomised patients). The Cr-51 EDTA GFRs cor-
related significantly with Gates’ original GFRs (Pearson’s r =
0.70, P <0.0001, 95 % confidence interval=0.54–0.81), but
GFRs from Gates’ original equation (70.1±20.5 mL/min/
1.73 m2) were significantly lower than those from the Cr-51
EDTA GFR test (97.0±31.9 mL/min/1.73 m2) (P <0.0001,
paired t test), which indicated that Gates’ original GFR sys-











with serum creatinine (sCr)-based
GFR estimation (eGFR) in 12
healthy volunteers. The
measurement of %renal uptake
(a) was more reproducible than
that of sCr levels (b).
Furthermore, the measurement of
Gates’ GFR (c) was also more
reproducible than that of eGFR
(d). Those results were
quantitatively supported in the
analyses of the %CVand ICC
(Table 2)
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In this regard, we performed a linear regression analysis
using the Cr-51 EDTA GFR as a dependent variable and
%renal uptake of Tc-99m DTPA as an explanatory variable
in order to derive a revised equation for improved GFR
measurement, and generated the following equation:
ImprovedGFR mL=minð Þ ¼ %renaluptake 11:7773ð Þ−0:7354
The revised equation has a greater slope than Gates’ orig-
inal equation. As a result, the new, improved GFRs were
always greater than Gates’ original GFRs for any given value
of %renal uptake, and the difference became greater with
higher values of %renal uptake (Fig. 3).
Using Gates’ original equation [GFR(mL/min)=(% renal
uptake×9.8127)−6.82519] [22], the %renal uptake had sig-
nificantly underestimated the Cr-51 EDTA GFRs, especially
in patients with high GFR levels, which is clearly demon-
strated by the Bland–Altman and correlation analyses
(Fig. 4a, c). However, the revised equation resulted in im-
proved GFRs (98.0±26.3 mL/min/1.73 m2) that were not
different from (P=0.7360) and maintained a significant cor-
relation with Cr-51 EDTA GFRs (r =0.73, P <0.0001, 95 %
CI=0.57–0.83) (Fig. 4b, d).
Application of the improved GFR to partial nephrectomy
Next, we retrospectively applied the improved GFR from the
revised equation to patients following partial nephrectomy
(n =25).
The total GFRs significantly decreased 3months (P <0.001)
and 6 months (P <0.001) post-surgery, which were clearly
demonstrated by the new improved GFRs (Fig. 5a). The
eGFRs also demonstrated the same tendency in GFR decline
over a 3- to 6-month period post-surgery, but the preoperative
eGFRs of 2 patients could not be provided because the formal
report for the eGFR was just greater than 60 mL/min/1.73 m2
without specific value and some aberrant data were noticed
(e.g. higher eGFRs at 6 months postoperatively than at baseline
or 3 months postoperatively; data now shown).
The individual GFR data from the revised GFR equation
clearly demonstrated the perioperative GFR changes in both
the kidneys that were operated on and the contralateral kid-
neys (Fig. 5b, c). The kidneys that were operated on suffered
from significant GFR declines 3 months post-surgery (P <
0.001), and the GFR declines continued until 6 months post-
surgery (P <0.001; Fig. 5b), whereas the contralateral kidneys
did not experience significant GFR changes over the 3- to 6-
month period post-surgery (P >0.05; Fig. 5c).
Discussion
Our current approach allowed reliable and accurate measure-
ment of moderate-to-high GFRs i.e. the GFR range of patients
undergoing nephron-sparing surgery or partial nephrectomy.
The revised GFR equation [GFR(mL/min)=(% renal uptake×
11.7773)−0.7354] derived from the linear regression analysis
between the gamma camera imaging-based parameter (%renal
uptake of Tc-99m DTPA) and Cr-51 EDTA GFR could be
successfully applied to the measurement of individual and
total GFRs post-partial nephrectomy.
In our institute, the gamma camera imaging-based mea-
surement of GFR was more reproducible than the sCr-based
eGFR (Fig. 2). Furthermore, the %CVs for %renal uptake
(5.41 %) and gamma camera-based GFR (6.60 %) in the
current study were not inferior to reported %CVs of inulin
clearance (7.1–11.3 %) [31], iothalamate clearance (6.3–
18.7 %) [32] or iohexol clearance (5.6–7.6 %) [33], suggest-
ing that the gamma camera imaging-based GFR from the
%renal uptake of Tc-99m DTPA is reliable enough for repeat-
ed measurements of GFR (Figs. 2 and 5).
Not only the reproducibility but also the accuracy is im-
portant for any GFR study to be used in clinical practice.
Gates’ original GFR method has been seriously criticised in
Table 2 Reproducibility of the %renal uptake, gamma camera-based GFR (Gates’ GFR), serum creatinine (sCr) level and eGFR values
%renal uptake sCr Gates’ GFR eGFR
%CV 5.41 % 9.50 % 6.60 % 10.8 %
ICC (95 % CI) 0.94 (0.80–0.98) 0.93 (0.74–0.98) 0.94 (0.80–0.98) 0.76 (0.17–0.93)
CV coefficient of variation, ICC intra-class coefficient, CI confidence interval
Fig. 3 Comparison of the equations for Gates’ original GFR and the new
improved GFR. The revised equation [GFR(mL/min)=(%renal uptake×
11.7773)−0.7354] always yielded higher GFRs than Gates’ original
equation [GFR(mL/min)=(% renal uptake×9.8127)−6.82519] in the
clinically relevant range of %renal uptake. Furthermore, greater %renal
uptake led to larger GFR increments with the revised GFR equation
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this regard [23, 25]. In the current study, Gates’ method of
GFR measurement could be significantly improved, particu-
larly for patients with normal-to-high GFRs (Figs. 3 and 4). In
fact, the clinical need for an accurate GFR measurement
technique was not as prevalent for high GFR levels compared
with lowGFR levels until nephron-sparing surgery and partial
nephrectomy became urological topics over the last decade
[34, 35]. Only indirect GFR surrogates or the unreliable eGFR
have been used so far instead of directly measured GFR [12,
13]. Thus, the clinical implication of the current study is that a
revised and improved Gates’ equation allows Tc-99m DTPA
GFR scintigraphy to play a critical role in the evaluation of
perioperative GFR changes in individual kidneys, especially
in partial nephrectomy patients.
Indeed, it is not difficult to examine the function of the
remnant kidney after total nephrectomy, because the function-
ing renal tissues come from only one remnant kidney. There-
fore, perioperative GFR changes after total nephrectomy have
been well described in both animal and clinical studies [36];
total nephrectomy would elicit compensatory hyperfunction
or hypertrophy of the remaining kidney up to several years
post-surgery, but would accelerate functional impairment of
the remnant kidney in the long run [37]. On the other hand,
only a few imaging studies have examined the functional
consequences of kidneys that were operated on and contralat-
eral kidneys after partial nephrectomy, and only indirect esti-
mates of GFR such as tubular function or parenchymal vol-
ume could be assessed [20]. One of the key issues in partial
nephrectomy is how to efficiently preserve the function of the
remnant parenchyma of the kidney that was operated on,
which is the major goal of modern nephron-sparing surgery
[16, 17]. Imaging studies like Tc-99m DTPA GFR scintigra-
phy reflecting the renal function of individual kidneys may
have a clinical impact in this regard. Figure 5 demonstrates
that the kidneys that were operated on suffered from GFR
declines 3 to 6 months post-partial nephrectomy (Fig. 5b),
whereas the contralateral kidneys did not show drastic chang-
es in their individual GFRs, albeit with a little fluctuation
(Fig. 5c). These findings would be explained as the loss of
functioning renal tissue from the surgery itself, the occurrence
of perioperative renal damage or a mixture of both in the
kidney that was operated on to the extent that compensatory
Mean of Cr-51 EDTA GFR and Gates GFR
(mL/min/1.73m2)




Fig. 4 Improvement in gamma camera-based GFR measurements using
the revised equation. The GFRs from Gates’ original equation of
[GFR(mL/min)=(%renal uptake×9.8127)−6.82519] were significantly
lower than those from the Cr-51 EDTA test (P <0.0001), particularly in
patients with a highGFR. TheBland–Altman (a) and correlation analyses
(c) readily demonstrate that the Gates’ GFRs systematically underesti-
mate the Cr-51 EDTAGFRs, especially within the range over 60mL/min/
1.73 m2 of Cr-51 EDTA GFR. On the other hand, the improved GFRs
from the revised equation of [GFR(mL/min)=(%renal uptake×11.7773)
−0.7354] were not significantly different from those of the Cr-51 EDTA
test (P=0.7360). It is of note that the revised equation minimises the GFR
differences between the improved GFRs and Cr-51 EDTA GFRs even at
high GFR levels as shown in the Bland–Altman analysis (b) and that the
improved GFRs and Cr-51 EDTA GFRs are consistent with the line of
equality as demonstrated in the correlation analysis (d)
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hyperfunction of the contralateral kidney was not required at
3–6 months post-surgery.
The revised equation for improved GFR [GFR(mL/
min)=(% renal uptake×11.7773)−0.7354] was derived from
the imaging parameter (%renal uptake of Tc-99m DTPA)
which had been originally adopted by Gates [GFR (mL/min)
= (%renal uptake × 9.8127) – 6.82519] [21, 22]. Linear
regression analysis was used in both cases, generating another
linear relationship between the two equations (Fig. 3), which
means that Gates’ GFR data obtained from the gamma cam-
eras containing commercial software can be converted to new,
improved GFR data with ease by using a simple conversion
equation like the following:
NewimprovedGFR ¼ OriginalGates’GFR 1:20021ð Þ þ 7:45626
The employment of Cr-51 EDTA plasma clearance as a
gold standard for true GFR has some advantages over Gates’
original method in which 24-h urinary creatinine clearance
was used [21]. Because of the technical difficulties of urine
collection over a 24-h period, the urinary clearance of creati-
nine has been reported to be less reproducible, even in com-
parison with eGFR [1, 32]. In fact, urine collection was the
main reason for the poor reproducibility of the inulin clearance
test [31]. On the other hand, Cr-51 EDTA clearance using
multiple plasma samples has been reported to be highly re-
producible (%CV=2.6–3.5 %) [38]. A small underestimation
of the inulin clearance GFR by Cr-51 EDTA GFR was report-
ed about 40 years ago [39]. Nonetheless, Cr-51 EDTA GFR
has been widely used as a reference standard because of its
reliability and convenience in a variety of trials investigating
new GFR agents [38]. Moreover, the kinetics of Cr-51 EDTA
and Tc-99mDTPA have been reported to be similar, justifying
the use of the Cr-51 EDTA test in the current study [40].
Inclusion of patients representing the entire range of im-
paired renal function is usually recommended in this kind of
establishment study for GFR. The patients recruited in the
current study were either healthy volunteers or almost
nephrologically disease-free oncology patients (Table 1). Tak-
ing into account this limitation, the current study results
should be applied mainly to nephrectomy patients. However,
the new Tc-99m DTPA GFR scintigraphy may be applicable
to low-GFR patients with medical illnesses, which warrants
further investigation.
In conclusion, this new Tc-99m DTPA GFR scintigraphic
method is very promising for the accurate evaluation of peri-
operative GFR changes in patients undergoing nephron-
sparing partial nephrectomy.
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Fig. 5 Assessment of
perioperative GFR changes using
the improved GFR equation. a
The preoperative total GFRs had
significantly decreased 3 months
(P<0.001) and 6 months post-
surgery (P<0.001), which was
readily demonstrated by the
improved GFRs. The kidneys that
were operated on had significant
GFR declines 3 months
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whereas the contralateral kidneys
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(P>0.05) (c). *P<0.001
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